Originally identified in cancer as tumor‐associated macrophages (TAMs), SPP1+ macrophages have since been implicated in various conditions, including aging, chronic inflammatory disorders, neurodegenerative diseases, and tissue remodeling (Figure 1). This evidence concerns the gene SPP1 and neurodegenerative disease.